It is possible that D-cycloserine acts independently of SPT inhibition to help ameliorate Krabbe disease by having anti-inflammatory effects, being a partial agonist of the NMDA receptor, by functioning as an antibiotic, or through other mechanisms. This evidence concerns the gene AGXT and Krabbe disease.